samdoc_mamc Profile Banner
Dr Sameer Rastogi Profile
Dr Sameer Rastogi

@samdoc_mamc

Followers
2K
Following
2K
Media
30
Statuses
871

Additional Professor, Sarcoma and GIST Medical Oncology Clinic, AIIMS, New Delhi, Passionate for the treatment of rare diseases like melanomas endocrine tumors

New Delhi, India
Joined February 2018
Don't wanna be here? Send us removal request.
@samdoc_mamc
Dr Sameer Rastogi
10 hours
RT @SachinSarcoma: Sarcoma Awareness Fact 15: . 🦴 What is Osteosarcoma?.A rare but aggressive #bonecancer, mostly seen in teenagers and you….
0
2
0
@samdoc_mamc
Dr Sameer Rastogi
6 days
RT @SachinSarcoma: To raise #awareness about #GIST and educate newly diagnosed GIST patients, we are organising GIST education program and….
0
2
0
@samdoc_mamc
Dr Sameer Rastogi
6 days
RT @mohamed35475330: July sarcoma awareness month with Professor @axel leCesne and great time and discussion in GRI-E Gustave Roussy inter….
0
2
0
@samdoc_mamc
Dr Sameer Rastogi
7 days
RT @tuttsakhil: Baseline D-dimers as predictive marker of efficacy of cemiplimab treatment in cutaneous squamous cell carcinoma - European….
0
1
0
@samdoc_mamc
Dr Sameer Rastogi
13 days
RT @SachinSarcoma: Sarcoma awareness fact 4:. It is important to get the blocks reviewed from a good institution as correct #pathology can….
0
3
0
@samdoc_mamc
Dr Sameer Rastogi
18 days
RT @ChordomaFDN: More than 140 experts from around the world came together last week to work toward improving the standard of care for chor….
0
6
0
@samdoc_mamc
Dr Sameer Rastogi
18 days
Adjuvant randomised trials in GIST.
@tuttsakhil
Dr Akhil Santhosh
18 days
List of adjuvant imatinib trials in resected GIST.@ASCO @samdoc_mamc
Tweet media one
0
0
11
@samdoc_mamc
Dr Sameer Rastogi
20 days
RT @APConley77: Excited to see how the research community will harmonize today to update clinical guidelines for chordoma!.@SilviaStacchia….
0
5
0
@samdoc_mamc
Dr Sameer Rastogi
1 month
RT @drsarahsam: Study that went under the radar at ASCO. WBRT with hippocampal sparing and memantine versus SRS for 5-20 brain metastases….
0
52
0
@samdoc_mamc
Dr Sameer Rastogi
1 month
RT @tuttsakhil: Adoptive Cell Transfer of Tumor-Infiltrating Lymphocytes for Metastatic Acral Lentiginous Melanoma @JCO_ASCO .
0
1
0
@samdoc_mamc
Dr Sameer Rastogi
1 month
RT @ecancer: Catequentinib improved median PFS to 3.42 months compared to 1.41 months with PBO (HR 0.54; p=0.0265). Results point to catequ….
0
4
0
@samdoc_mamc
Dr Sameer Rastogi
1 month
Pleased to share Phase 2 trial results for low-dose regorafenib in relapsed synovial sarcoma. N=25, 76% previously exposed to pazopanib. 3-month progression-free rate: 56%. Median progression-free survival: 5 mths. @oncodaily @JCOGO_ASCO
Tweet media one
6
14
56
@samdoc_mamc
Dr Sameer Rastogi
1 month
RT @Marta_GustavoN: Phyllodes tumors of the Breast
Tweet media one
0
14
0
@samdoc_mamc
Dr Sameer Rastogi
1 month
RT @phyllodestumor: A phyllodes tumor develops in the connective tissue of the breast. This type of tumor is usually fast-growing but hardl….
0
3
0
@samdoc_mamc
Dr Sameer Rastogi
1 month
RT @HTawbi_MD: Primary results of RELATIVITY-098 showing that adjuvant nivo+rela does not improve RFS over nivo alone, HR 1.01, biomarker d….
0
8
0
@samdoc_mamc
Dr Sameer Rastogi
1 month
RT @VivekSubbiah: ⭐️🚨Delighted to report 👉🏼Efficacy and safety of pralsetinib in RET fusion-positive solid tumors: Final data from the ARRO….
0
7
0
@samdoc_mamc
Dr Sameer Rastogi
2 months
RT @SachinSarcoma: Organised 264 th #sarcoma #supportgroup meeting today where Dr Subhash gave educational session on Dealing with Comorbid….
0
2
0
@samdoc_mamc
Dr Sameer Rastogi
2 months
RT @srothschild: So proud of @stern_sydney for beautifully presenting the data on pediatric #TGCT at #ASCO25. Great to see lots of interest….
0
6
0